Back to BlackRock, Inc. BlackRock, Inc.

ABUSABUS
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ARBUTUS BIOPHARMA CORP

BlackRock, Inc. holds 13.8M shares of ABUS (ARBUTUS BIOPHARMA CORP), worth $66.1M as of 2026-Q2. The position was increased (+6.2% shares). ABUS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$66.1M

Current Shares

13.8M

Total Value Change

+$19M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
13.8M
+6.2%
$66.1M0.0%$4.80
31
2026-Q1
Decreased
13M
-0.7%
$58.4M0.0%$4.50
0
2025-Q4
Increased
13.1M
+3.0%
$62.8M0.0%$4.81
30
2025-Q3
Decreased
12.7M
-1.5%
$57.6M0.0%$4.54
0
2025-Q2
Increased
12.9M
+0.8%
$39.8M0.0%$3.09
29
2025-Q1
Decreased
12.8M
-1.3%
$44.6M0.0%$3.49
0
2024-Q4
Increased
12.9M
+5.9%
$42.3M0.0%$3.27
31
2024-Q3
First report
12.2M
-
$47M0.0%$3.85
0

Other major holders of ABUS: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used